Microbiome-derived metabolite effects on intestinal barrier integrity and immune cell response to infection

• Published in: Microbiology (Society for General Microbiology) Vol. 170; no. 10
• Main Authors: Adams, Lauren, Li, Xiang, Burchmore, Richard, Goodwin, Richard J A, Wall, Daniel M
• Format: Journal Article
• Language: English
• Published: England 01.10.2024
• Subjects: Animals; Butyrates - metabolism; Butyrates - pharmacology; Escherichia coli - drug effects; Gastrointestinal Microbiome - drug effects; Humans; Interleukin-8 - metabolism; Intestinal Mucosa - immunology; Intestinal Mucosa - metabolism; Intestinal Mucosa - microbiology; Macrophages - drug effects; Macrophages - immunology; Macrophages - microbiology; Methylamines - metabolism; Methylamines - pharmacology; Mice; Tryptophan - metabolism; Tryptophan - pharmacology; Tumor Necrosis Factor-alpha - metabolism; immune response; intestinal barrier; metabolites; microbiome
• ISSN: 1350-0872; 1465-2080; 1465-2080
• DOI: 10.1099/mic.0.001504

The gut microbiota exerts a significant influence on human health and disease. While compositional changes in the gut microbiota in specific diseases can easily be determined, we lack a detailed mechanistic understanding of how these changes exert effects at the cellular level. However, the putative local and systemic effects on human physiology that are attributed to the gut microbiota are clearly being mediated through molecular communication. Here, we determined the effects of gut microbiome-derived metabolites l-tryptophan, butyrate, trimethylamine (TMA), 3-methyl-4-(trimethylammonio)butanoate (3,4-TMAB), 4-(trimethylammonio)pentanoate (4-TMAP), ursodeoxycholic acid (UDCA), glycocholic acid (GCA) and benzoate on the first line of defence in the gut. Using models of intestinal barrier integrity and studying the interaction of macrophages with pathogenic and non-pathogenic bacteria, we could ascertain the influence of these metabolites at the cellular level at physiologically relevant concentrations. Nearly all metabolites exerted positive effects on barrier function, but butyrate prevented a reduction in transepithelial resistance in the presence of the pathogen , despite inducing increased apoptosis and exerting increased cytotoxicity. Induction of IL-8 was unaffected by all metabolites, but GCA stimulated increased intra-macrophage growth of and tumour necrosis-alpha (TNF-α) release. Butyrate, 3,4-TMAB and benzoate all increased TNF-α release independent of bacterial replication. These findings reiterate the complexity of understanding microbiome effects on host physiology and underline that microbiome metabolites are crucial mediators of barrier function and the innate response to infection. Understanding these metabolites at the cellular level will allow us to move towards a better mechanistic understanding of microbiome influence over host physiology, a crucial step in advancing microbiome research.